The chart shows Sorrento Therapeutics ( SRNE -3.97% ) actually has the most coronavirus candidates in development. The company has a total of 18 candidates. These include potential products such as a neutralizing antibody nasal spray, an antiviral pill, and an omicron mRNA vaccine. By comparison, Moderna and Pfizer each have 10 candidates in development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,